[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and Europe Antihistamine Drugs Market - Analysis and Outlook to 2022

September 2017 | 116 pages | ID: GBC90D48AF5EN
EU Research

US$ 2,960.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents a comprehensive overview of the Antihistamine Drugs market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Antihistamine Drugs industry.

This report focuses Global and Europe market, including details as following:

Key Players
  • Akorn Pharmaceuticals (US)
  • Almirall S.A. (Spain)
  • Auctus Pharma Limited (India)
  • Bayer SA-NV (Belgium)
  • Kyowa Hakko Kirin Co.,Ltd. (Japan)
  • MEDA Pharma GmbH & Co. KG (Germany)
  • Merck Sharp & Dohme Limited (UK)
  • Nippon Boehringer Ingelheim Co.,Ltd. (Japan)
  • Pfizer Pharmaceutical Company (US)
  • Sanofi Winthrop Industries (France)
  • Santen Pharmaceutical Co.,Ltd. (Japan)
  • Schering-Plough Europe (US)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceutical Industries (Israel)
  • Therabel Europe Limited (Ireland)
  • UCB Pharma GmbH (Germany)
  • Vintage Pharmaceuticals (US)
Key Regions
  • North America
    • United States
    • Canada
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Russia
    • Netherland
    • Others
  • Asia & Pacific
    • China
    • Japan
    • India
    • Korea
    • Australia
    • Southeast Asia
      • Indonesia
      • Thailand
      • Philippines
      • Vietnam
      • Singapore
      • Malaysia
      • Others
  • Africa & Middle East
    • South Africa
    • Egypt
    • Turkey
    • Saudi Arabia
    • Iran
    • Others
Key Product Type
  • By Antihistanmines: Azelastine, Brompheniramine, Carbinoxamine, Cetirizine, Other.
  • By Access: Prescription, OTC.
Key Applications
  • Department of respiration
  • Otolaryngology
  • Department of dermatology
  • Pharmacy
1 MARKET OUTLINE

1.1 Research Methodology
  1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
  1.1.2 Data Source
Secondary Sources
Primary Sources
  1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
  1.5.1 Antihistamine Drugs Industry Chain Structure
    1.5.1.1 R&D
    1.5.1.2 Raw Materials (Components)
    1.5.1.3 Manufacturing Plants
    1.5.1.4 Regional Trading (Import Export and Local Sales)
    1.5.1.5 Online Sales Channel
    1.5.1.6 Offline Channel
    1.5.1.7 End Users
  1.5.2 Antihistamine Drugs Manufacturing
    1.5.2.1 Key Components
    1.5.2.2 Assembly Manufacturing
  1.5.3 Consumer Preference
  1.5.4 Behavioral Habits
  1.5.5 Marketing Environment
1.6 SWOT Analysis
1.7 Feasibility Analysis
1.8 Development Trend and Research Conclusion
  1.8.1 Development Trend
  1.8.2 Research Conclusion

2 GLOBAL ANTIHISTAMINE DRUGS PRODUCT OVERVIEW

2.1 Global Antihistamine Drugs Market Sales Volume Revenue and Price 2012-2017
2.2 Antihistamine Drugs, by Antihistanmines 2012-2017
  2.2.1 Global Antihistamine Drugs Sales Market Share by Antihistanmines 2012-2017
  2.2.2 Global Antihistamine Drugs Revenue Market Share by Antihistanmines 2012-2017
  2.2.3 Global Antihistamine Drugs Price by Antihistanmines 2012-2017
  2.2.4 Azelastine
  2.2.5 Brompheniramine
  2.2.6 Carbinoxamine
  2.2.7 Cetirizine
  2.2.8 Other
2.3 Antihistamine Drugs, by Access 2012-2017
  2.3.1 Global Antihistamine Drugs Sales Market Share by Access 2012-2017
  2.3.2 Global Antihistamine Drugs Revenue Market Share by Access 2012-2017
  2.3.3 Global Antihistamine Drugs Price by Access 2012-2017
  2.3.4 Prescription
  2.3.5 OTC

3 EUROPE ANTIHISTAMINE DRUGS PRODUCT OVERVIEW

3.1 Europe Antihistamine Drugs Market Sales Volume Revenue and Price 2012-2017
3.2 Antihistamine Drugs, by Antihistanmines 2012-2017
  3.2.1 Europe Antihistamine Drugs Sales Market Share by Antihistanmines 2012-2017
  3.2.2 Europe Antihistamine Drugs Revenue Market Share by Antihistanmines 2012-2017
  3.2.3 Europe Antihistamine Drugs Price by Antihistanmines 2012-2017
  3.2.4 Azelastine
  3.2.5 Brompheniramine
  3.2.6 Carbinoxamine
  3.2.7 Cetirizine
  3.2.8 Other
3.3 Antihistamine Drugs, by Access 2012-2017
  3.3.1 Europe Antihistamine Drugs Sales Market Share by Access 2012-2017
  3.3.2 Europe Antihistamine Drugs Revenue Market Share by Access 2012-2017
  3.3.3 Europe Antihistamine Drugs Price by Access 2012-2017
  3.3.4 Prescription
  3.3.5 OTC

4 ANTIHISTAMINE DRUGS TOP COMPANIES PROFILE

4.1 Akorn Pharmaceuticals (US)
  4.1.1 Akorn Pharmaceuticals (US) Company Details and Competitors
  4.1.2 Akorn Pharmaceuticals (US) Key Antihistamine Drugs Models and Performance
  4.1.3 Akorn Pharmaceuticals (US) Antihistamine Drugs Business SWOT Analysis and Forecast
  4.1.4 Akorn Pharmaceuticals (US) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
4.2 Almirall S.A. (Spain)
  4.2.1 Almirall S.A. (Spain) Company Details and Competitors
  4.2.2 Almirall S.A. (Spain) Key Antihistamine Drugs Models and Performance
  4.2.3 Almirall S.A. (Spain) Antihistamine Drugs Business SWOT Analysis and Forecast
  4.2.4 Almirall S.A. (Spain) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
4.3 Auctus Pharma Limited (India)
  4.3.1 Auctus Pharma Limited (India) Company Details and Competitors
  4.3.2 Auctus Pharma Limited (India) Key Antihistamine Drugs Models and Performance
  4.3.3 Auctus Pharma Limited (India) Antihistamine Drugs Business SWOT Analysis and Forecast
  4.3.4 Auctus Pharma Limited (India) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
4.4 Bayer SA-NV (Belgium)
  4.4.1 Bayer SA-NV (Belgium) Company Details and Competitors
  4.4.2 Bayer SA-NV (Belgium) Key Antihistamine Drugs Models and Performance
  4.4.3 Bayer SA-NV (Belgium) Antihistamine Drugs Business SWOT Analysis and Forecast
  4.4.4 Bayer SA-NV (Belgium) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
4.5 Kyowa Hakko Kirin Co.,Ltd. (Japan)
  4.5.1 Kyowa Hakko Kirin Co.,Ltd. (Japan) Company Details and Competitors
  4.5.2 Kyowa Hakko Kirin Co.,Ltd. (Japan) Key Antihistamine Drugs Models and Performance
  4.5.3 Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Business SWOT Analysis and Forecast
  4.5.4 Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
4.6 MEDA Pharma GmbH & Co. KG (Germany)
  4.6.1 MEDA Pharma GmbH & Co. KG (Germany) Company Details and Competitors
  4.6.2 MEDA Pharma GmbH & Co. KG (Germany) Key Antihistamine Drugs Models and Performance
  4.6.3 MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Business SWOT Analysis and Forecast
  4.6.4 MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
4.7 Merck Sharp & Dohme Limited (UK)
  4.7.1 Merck Sharp & Dohme Limited (UK) Company Details and Competitors
  4.7.2 Merck Sharp & Dohme Limited (UK) Key Antihistamine Drugs Models and Performance
  4.7.3 Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Business SWOT Analysis and Forecast
  4.7.4 Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
4.8 Nippon Boehringer Ingelheim Co.,Ltd. (Japan)
  4.8.1 Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Company Details and Competitors
  4.8.2 Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Key Antihistamine Drugs Models and Performance
  4.8.3 Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Business SWOT Analysis and Forecast
  4.8.4 Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
4.9 Pfizer Pharmaceutical Company (US)
  4.9.1 Pfizer Pharmaceutical Company (US) Company Details and Competitors
  4.9.2 Pfizer Pharmaceutical Company (US) Key Antihistamine Drugs Models and Performance
  4.9.3 Pfizer Pharmaceutical Company (US) Antihistamine Drugs Business SWOT Analysis and Forecast
  4.9.4 Pfizer Pharmaceutical Company (US) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
4.10 Sanofi Winthrop Industries (France)
  4.10.1 Sanofi Winthrop Industries (France) Company Details and Competitors
  4.10.2 Sanofi Winthrop Industries (France) Key Antihistamine Drugs Models and Performance
  4.10.3 Sanofi Winthrop Industries (France) Antihistamine Drugs Business SWOT Analysis and Forecast
  4.10.4 Sanofi Winthrop Industries (France) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
4.11 Santen Pharmaceutical Co.,Ltd. (Japan)
4.12 Schering-Plough Europe (US)
4.13 Sun Pharmaceutical Industries Ltd. (India)
4.14 Teva Pharmaceutical Industries (Israel)
4.15 Therabel Europe Limited (Ireland)
4.16 UCB Pharma GmbH (Germany)
4.17 Vintage Pharmaceuticals (US)

5 ANTIHISTAMINE DRUGS BY REGIONS 2012-2017

5.1 Global Antihistamine Drugs Sales Market Share by Regions 2012-2017
5.2 Global Antihistamine Drugs Revenue Market Share by Regions 2012-2017
5.3 Global Antihistamine Drugs Price by Regions 2012-2017
5.4 North America
  5.4.1 United States
  5.4.2 Canada
5.5 Latin America
  5.5.1 Mexico
  5.5.2 Brazil
  5.5.3 Argentina
  5.5.4 Others in Latin America
5.6 Europe
  5.6.1 Germany
  5.6.2 United Kingdom
  5.6.3 France
  5.6.4 Italy
  5.6.5 Spain
  5.6.6 Russia
  5.6.7 Netherland
  5.6.8 Others in Europe
5.7 Asia & Pacific
  5.7.1 China
  5.7.2 Japan
  5.7.3 India
  5.7.4 Korea
  5.7.5 Australia
  5.7.6 Southeast Asia
    5.7.6.1 Indonesia
    5.7.6.2 Thailand
    5.7.6.3 Philippines
    5.7.6.4 Vietnam
    5.7.6.5 Singapore
    5.7.6.6 Malaysia
    5.7.6.7 Others in Southeast Asia
5.8 Africa & Middle East
  5.8.1 South Africa
  5.8.2 Egypt
  5.8.3 Turkey
  5.8.4 Saudi Arabia
  5.8.5 Iran
  5.8.6 Others in Africa & Middle East

6 GLOBALANTIHISTAMINE DRUGS BY PLAYERS 2012-2017

6.1 Global Antihistamine Drugs Sales Volume Market Share by Brands 2012-2017
6.2 Global Antihistamine Drugs Revenue Share by Brands 2012-2017
6.3 Global Top Players Antihistamine Drugs Key Product Model and Market Performance
6.4 Global Top Players Antihistamine Drugs Key Target Consumers and Market Performance

7 EUROPEANTIHISTAMINE DRUGS BY PLAYERS 2012-2017

7.1 Europe Antihistamine Drugs Sales Volume Market Share by Brands 2012-2017
7.2 Europe Antihistamine Drugs Revenue Share by Brands 2012-2017
7.3 Europe Top Players Antihistamine Drugs Key Product Model and Market Performance
7.4 Europe Top Players Antihistamine Drugs Key Target Consumers and Market Performance

8 GLOBAL ANTIHISTAMINE DRUGS BY CONSUMER 2012-2017

8.1 Global Antihistamine Drugs Sales Market Share by Consumer 2012-2017
8.2 Department of respiration
8.3 Otolaryngology
8.4 Department of dermatology
8.5 Pharmacy
8.6 Consuming Habit and Preference

9 EUROPE ANTIHISTAMINE DRUGS BY CONSUMER 2012-2017

9.1 Europe Antihistamine Drugs Sales Market Share by Consumer 2012-2017
9.2 Department of respiration
9.3 Otolaryngology
9.4 Department of dermatology
9.5 Pharmacy
9.6 Consuming Habit and Preference

10 GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

10.1 Global Antihistamine Drugs Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Antihistamine Drugs Sales (K Units) Forecast by Regions (2017-2022)
10.3 Global Antihistamine Drugs Sales (K Units) Forecast by Application (2017-2022)
10.4 Global Antihistamine Drugs Sales (K Units) Forecast by Antihistanmines (2017-2022)
10.5 Global Antihistamine Drugs Sales (K Units) Forecast by Access (2017-2022)

11 EUROPE ANTIHISTAMINE DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 Europe Antihistamine Drugs Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 Europe Antihistamine Drugs Sales (K Units) Forecast by Regions (2017-2022)
11.3 Europe Antihistamine Drugs Sales (K Units) Forecast by Application (2017-2022)
11.4 Europe Antihistamine Drugs Sales (K Units) Forecast by Antihistanmines (2017-2022)
11.5 Europe Antihistamine Drugs Sales (K Units) Forecast by Access (2017-2022)

LIST OF TABLES AND FIGURES

Table Global Antihistamine Drugs Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global Antihistamine Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Antihistamine Drugs Sales Volume (K Units) and Growth Rate (2012-2017)
Table Global Antihistamine Drugs Sales (K Units) by Antihistanmines (2012-2017)
Table Global Antihistamine Drugs Sales Market Share by Antihistanmines (2012-2017)
Figure Global Antihistamine Drugs Sales Market Share by Antihistanmines in 2016
Table Global Antihistamine Drugs Revenue (Million USD) by Antihistanmines (2012-2017)
Table Global Antihistamine Drugs Revenue Market Share by Antihistanmines (2012-2017)
Figure Global Antihistamine Drugs Revenue Market Share by Antihistanmines in 2016
Table Global Antihistamine Drugs Price (USD/Unit) by Antihistanmines (2012-2017)
Table Top Players of Azelastine Antihistamine Drugs Products List
Figure Global Azelastine Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Brompheniramine Antihistamine Drugs Products List
Figure Global Brompheniramine Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Carbinoxamine Antihistamine Drugs Products List
Figure Global Carbinoxamine Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Cetirizine Antihistamine Drugs Products List
Figure Global Cetirizine Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Other Antihistamine Drugs Products List
Figure Global Other Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Global Antihistamine Drugs Sales (K Units) by Access (2012-2017)
Table Global Antihistamine Drugs Sales Market Share by Access (2012-2017)
Figure Global Antihistamine Drugs Sales Market Share by Access in 2016
Table Global Antihistamine Drugs Revenue (Million USD) by Access (2012-2017)
Table Global Antihistamine Drugs Revenue Market Share by Access (2012-2017)
Figure Global Antihistamine Drugs Revenue Market Share by Access in 2016
Table Global Antihistamine Drugs Price (USD/Unit) by Access (2012-2017)
Table Top Players of Prescription Antihistamine Drugs Products List
Figure Global Prescription Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of OTC Antihistamine Drugs Products List
Figure Global OTC Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Global Antihistamine Drugs Sales (K Units) by (2012-2017)
Table Global Antihistamine Drugs Sales Market Share by (2012-2017)
Figure Global Antihistamine Drugs Sales Market Share by in 2016
Table Global Antihistamine Drugs Revenue (Million USD) by (2012-2017)
Table Global Antihistamine Drugs Revenue Market Share by (2012-2017)
Figure Global Antihistamine Drugs Revenue Market Share by in 2016
Table Global Antihistamine Drugs Price (USD/Unit) by (2012-2017)
Table Global Antihistamine Drugs Sales (K Units) by (2012-2017)
Table Global Antihistamine Drugs Sales Market Share by (2012-2017)
Figure Global Antihistamine Drugs Sales Market Share by in 2016
Table Global Antihistamine Drugs Revenue (Million USD) by (2012-2017)
Table Global Antihistamine Drugs Revenue Market Share by (2012-2017)
Figure Global Antihistamine Drugs Revenue Market Share by in 2016
Table Global Antihistamine Drugs Price (USD/Unit) by (2012-2017)
Table Europe Antihistamine Drugs Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Europe Antihistamine Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Antihistamine Drugs Sales Volume (K Units) and Growth Rate (2012-2017)
Table Europe Antihistamine Drugs Sales (K Units) by Antihistanmines (2012-2017)
Table Europe Antihistamine Drugs Sales Market Share by Antihistanmines (2012-2017)
Figure Europe Antihistamine Drugs Sales Market Share by Antihistanmines in 2016
Table Europe Antihistamine Drugs Revenue (Million USD) by Antihistanmines (2012-2017)
Table Europe Antihistamine Drugs Revenue Market Share by Antihistanmines (2012-2017)
Figure Europe Antihistamine Drugs Revenue Market Share by Antihistanmines in 2016
Table Europe Antihistamine Drugs Price (USD/Unit) by Antihistanmines (2012-2017)
Table Top Players of Azelastine Antihistamine Drugs Products List
Figure Europe Azelastine Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Brompheniramine Antihistamine Drugs Products List
Figure Europe Brompheniramine Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Carbinoxamine Antihistamine Drugs Products List
Figure Europe Carbinoxamine Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Cetirizine Antihistamine Drugs Products List
Figure Europe Cetirizine Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Other Antihistamine Drugs Products List
Figure Europe Other Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Europe Antihistamine Drugs Sales (K Units) by Access (2012-2017)
Table Europe Antihistamine Drugs Sales Market Share by Access (2012-2017)
Figure Europe Antihistamine Drugs Sales Market Share by Access in 2016
Table Europe Antihistamine Drugs Revenue (Million USD) by Access (2012-2017)
Table Europe Antihistamine Drugs Revenue Market Share by Access (2012-2017)
Figure Europe Antihistamine Drugs Revenue Market Share by Access in 2016
Table Europe Antihistamine Drugs Price (USD/Unit) by Access (2012-2017)
Table Top Players of Prescription Antihistamine Drugs Products List
Figure Europe Prescription Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of OTC Antihistamine Drugs Products List
Figure Europe OTC Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Europe Antihistamine Drugs Sales (K Units) by (2012-2017)
Table Europe Antihistamine Drugs Sales Market Share by (2012-2017)
Figure Europe Antihistamine Drugs Sales Market Share by in 2016
Table Europe Antihistamine Drugs Revenue (Million USD) by (2012-2017)
Table Europe Antihistamine Drugs Revenue Market Share by (2012-2017)
Figure Europe Antihistamine Drugs Revenue Market Share by in 2016
Table Europe Antihistamine Drugs Price (USD/Unit) by (2012-2017)
Table Europe Antihistamine Drugs Sales (K Units) by (2012-2017)
Table Europe Antihistamine Drugs Sales Market Share by (2012-2017)
Figure Europe Antihistamine Drugs Sales Market Share by in 2016
Table Europe Antihistamine Drugs Revenue (Million USD) by (2012-2017)
Table Europe Antihistamine Drugs Revenue Market Share by (2012-2017)
Figure Europe Antihistamine Drugs Revenue Market Share by in 2016
Table Europe Antihistamine Drugs Price (USD/Unit) by (2012-2017)
Table Akorn Pharmaceuticals (US) Company Details and Competitors
Table Akorn Pharmaceuticals (US) Key Antihistamine Drugs Models and Performance
Table Akorn Pharmaceuticals (US) Antihistamine Drugs Business SWOT Analysis and Forecast
Table Akorn Pharmaceuticals (US) Antihistamine Drugs Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Akorn Pharmaceuticals (US) Antihistamine Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Akorn Pharmaceuticals (US) Antihistamine Drugs Sales Market Share (%) in Global (2012-2017)
Figure Akorn Pharmaceuticals (US) Antihistamine Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Akorn Pharmaceuticals (US) Antihistamine Drugs Revenue Market Share (%) in Global (2012-2017)
Table Almirall S.A. (Spain) Company Details and Competitors
Table Almirall S.A. (Spain) Key Antihistamine Drugs Models and Performance
Table Almirall S.A. (Spain) Antihistamine Drugs Business SWOT Analysis and Forecast
Table Almirall S.A. (Spain) Antihistamine Drugs Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Almirall S.A. (Spain) Antihistamine Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Almirall S.A. (Spain) Antihistamine Drugs Sales Market Share (%) in Global (2012-2017)
Figure Almirall S.A. (Spain) Antihistamine Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Almirall S.A. (Spain) Antihistamine Drugs Revenue Market Share (%) in Global (2012-2017)
Table Auctus Pharma Limited (India) Company Details and Competitors
Table Auctus Pharma Limited (India) Key Antihistamine Drugs Models and Performance
Table Auctus Pharma Limited (India) Antihistamine Drugs Business SWOT Analysis and Forecast
Table Auctus Pharma Limited (India) Antihistamine Drugs Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Auctus Pharma Limited (India) Antihistamine Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Auctus Pharma Limited (India) Antihistamine Drugs Sales Market Share (%) in Global (2012-2017)
Figure Auctus Pharma Limited (India) Antihistamine Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Auctus Pharma Limited (India) Antihistamine Drugs Revenue Market Share (%) in Global (2012-2017)
Table Bayer SA-NV (Belgium) Company Details and Competitors
Table Bayer SA-NV (Belgium) Key Antihistamine Drugs Models and Performance
Table Bayer SA-NV (Belgium) Antihistamine Drugs Business SWOT Analysis and Forecast
Table Bayer SA-NV (Belgium) Antihistamine Drugs Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Bayer SA-NV (Belgium) Antihistamine Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Bayer SA-NV (Belgium) Antihistamine Drugs Sales Market Share (%) in Global (2012-2017)
Figure Bayer SA-NV (Belgium) Antihistamine Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Bayer SA-NV (Belgium) Antihistamine Drugs Revenue Market Share (%) in Global (2012-2017)
Table Kyowa Hakko Kirin Co.,Ltd. (Japan) Company Details and Competitors
Table Kyowa Hakko Kirin Co.,Ltd. (Japan) Key Antihistamine Drugs Models and Performance
Table Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Business SWOT Analysis and Forecast
Table Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Sales Market Share (%) in Global (2012-2017)
Figure Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Revenue Market Share (%) in Global (2012-2017)
Table MEDA Pharma GmbH & Co. KG (Germany) Company Details and Competitors
Table MEDA Pharma GmbH & Co. KG (Germany) Key Antihistamine Drugs Models and Performance
Table MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Business SWOT Analysis and Forecast
Table MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Sales Market Share (%) in Global (2012-2017)
Figure MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Revenue Market Share (%) in Global (2012-2017)
Table Merck Sharp & Dohme Limited (UK) Company Details and Competitors
Table Merck Sharp & Dohme Limited (UK) Key Antihistamine Drugs Models and Performance
Table Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Business SWOT Analysis and Forecast
Table Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Sales Market Share (%) in Global (2012-2017)
Figure Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Revenue Market Share (%) in Global (2012-2017)
Table Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Company Details and Competitors
Table Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Key Antihistamine Drugs Models and Performance
Table Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Business SWOT Analysis and Forecast
Table Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Sales Market Share (%) in Global (2012-2017)
Figure Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Revenue Market Share (%) in Global (2012-2017)
Table Pfizer Pharmaceutical Company (US) Company Details and Competitors
Table Pfizer Pharmaceutical Company (US) Key Antihistamine Drugs Models and Performance
Table Pfizer Pharmaceutical Company (US) Antihistamine Drugs Business SWOT Analysis and Forecast
Table Pfizer Pharmaceutical Company (US) Antihistamine Drugs Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Pfizer Pharmaceutical Company (US) Antihistamine Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Pfizer Pharmaceutical Company (US) Antihistamine Drugs Sales Market Share (%) in Global (2012-2017)
Figure Pfizer Pharmaceutical Company (US) Antihistamine Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Pfizer Pharmaceutical Company (US) Antihistamine Drugs Revenue Market Share (%) in Global (2012-2017)
Table Sanofi Winthrop Industries (France) Company Details and Competitors
Table Sanofi Winthrop Industries (France) Key Antihistamine Drugs Models and Performance
Table Sanofi Winthrop Industries (France) Antihistamine Drugs Business SWOT Analysis and Forecast
Table Sanofi Winthrop Industries (France) Antihistamine Drugs Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Sanofi Winthrop Industries (France) Antihistamine Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Sanofi Winthrop Industries (France) Antihistamine Drugs Sales Market Share (%) in Global (2012-2017)
Figure Sanofi Winthrop Industries (France) Antihistamine Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Sanofi Winthrop Industries (France) Antihistamine Drugs Revenue Market Share (%) in Global (2012-2017)
Table Santen Pharmaceutical Co.,Ltd. (Japan) Company Details and Competitors
Table Schering-Plough Europe (US) Company Details and Competitors
Table Sun Pharmaceutical Industries Ltd. (India) Company Details and Competitors
Table Teva Pharmaceutical Industries (Israel) Company Details and Competitors
Table Therabel Europe Limited (Ireland) Company Details and Competitors
Table UCB Pharma GmbH (Germany) Company Details and Competitors
Table Vintage Pharmaceuticals (US) Company Details and Competitors
Table Global Antihistamine Drugs Sales (K Units) by Regions (2012-2017)
Table Global Antihistamine Drugs Sales Share by Regions (2012-2017)
Figure Global Antihistamine Drugs Sales Market Share by Regions in 2016
Figure Global Antihistamine Drugs Sales Market Share by Regions in 2017
Table Global Antihistamine Drugs Revenue (Million USD) by Regions (2012-2017)
Table Global Antihistamine Drugs Revenue Market Share by Regions (2012-2017)
Figure Global Antihistamine Drugs Revenue Market Share by Regions in 2016
Figure Global Antihistamine Drugs Revenue Market Share by Regions in 2017
Table Global Antihistamine Drugs Price (USD/Unit) by Regions (2012-2017)
Table North America Antihistamine Drugs Sales (K Units) by Regions (2012-2017)
Table North America Antihistamine Drugs Revenue (Million USD) by Regions (2012-2017)
Figure North America Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Latin America Antihistamine Drugs Sales (K Units) by Regions (2012-2017)
Table Latin America Antihistamine Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Europe Antihistamine Drugs Sales (K Units) by Regions (2012-2017)
Table Europe Antihistamine Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Europe Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Asia & Pacific Antihistamine Drugs Sales (K Units) by Regions (2012-2017)
Table Asia & Pacific Antihistamine Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Africa & Middle East Antihistamine Drugs Sales (K Units) by Regions (2012-2017)
Table Africa & Middle East Antihistamine Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Global Antihistamine Drugs Sales Volume (K Units) by Key Players 2012-2017
Table Global Antihistamine Drugs Sales Volume Market Share by Key Players 2012-2017
Figure Global Antihistamine Drugs Sales Volume Market Share by Key Players 2016
Figure Global Antihistamine Drugs Sales Volume Market Share by Key Players 2017
Table Global Antihistamine Drugs Revenue (Million USD) by Key Players 2012-2017
Table Global Antihistamine Drugs Revenue Market Share by Key Players 2012-2017
Figure Global Antihistamine Drugs Revenue Market Share by Key Players 2016
Figure Global Antihistamine Drugs Revenue Market Share by Key Players 2017
Table Global Top Players Key Product Model and Market Performance
Table Global Top Players Key Target Consumers and Market Performance
Table Europe Antihistamine Drugs Sales Volume (K Units) by Key Players 2012-2017
Table Europe Antihistamine Drugs Sales Volume Market Share by Key Players 2012-2017
Figure Europe Antihistamine Drugs Sales Volume Market Share by Key Players 2016
Figure Europe Antihistamine Drugs Sales Volume Market Share by Key Players 2017
Table Europe Antihistamine Drugs Revenue (Million USD) by Key Players 2012-2017
Table Europe Antihistamine Drugs Revenue Market Share by Key Players 2012-2017
Figure Europe Antihistamine Drugs Revenue Market Share by Key Players 2016
Figure Europe Antihistamine Drugs Revenue Market Share by Key Players 2017
Table Europe Top Players Key Product Model and Market Performance
Table Europe Top Players Key Target Consumers and Market Performance
Table Global Antihistamine Drugs Sales (K Units) by Consumer (2012-2017)
Figure Global Antihistamine Drugs Sales Market Share by Consumer (2012-2017)
Figure Global Antihistamine Drugs Sales Market Share by Consumer in 2016
Figure Global Department of respiration Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Global Otolaryngology Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Global Department of dermatology Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Global Pharmacy Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Europe Antihistamine Drugs Sales (K Units) by Consumer (2012-2017)
Figure Europe Antihistamine Drugs Sales Market Share by Consumer (2012-2017)
Figure Europe Antihistamine Drugs Sales Market Share by Consumer in 2016
Figure Europe Department of respiration Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Otolaryngology Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Department of dermatology Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Pharmacy Antihistamine Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Global Antihistamine Drugs Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Antihistamine Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Antihistamine Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table Global Antihistamine Drugs Sales (K Units) Forecast by Regions (2017-2022)
Table Global Antihistamine Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Antihistamine Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Antihistamine Drugs Sales Volume Share Forecast by Regions in 2022
Table Global Antihistamine Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Antihistamine Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Antihistamine Drugs Sales Volume Market Share Forecast by Application in 2022
Table Global Antihistamine Drugs Sales (K Units) Forecast by Antihistanmines (2017-2022)
Figure Global Antihistamine Drugs Sales (K Units) Forecast by Antihistanmines (2017-2022)
Figure Global Antihistamine Drugs Sales Volume Market Share Forecast by Antihistanmines in 2022
Table Global Antihistamine Drugs Sales (K Units) Forecast by Access (2017-2022)
Figure Global Antihistamine Drugs Sales (K Units) Forecast by Access (2017-2022)
Figure Global Antihistamine Drugs Sales Volume Market Share Forecast by Access in 2022
Figure Europe Antihistamine Drugs Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Antihistamine Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Europe Antihistamine Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table Europe Antihistamine Drugs Sales (K Units) Forecast by Regions (2017-2022)
Table Europe Antihistamine Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Europe Antihistamine Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Europe Antihistamine Drugs Sales Volume Share Forecast by Regions in 2022
Table Europe Antihistamine Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Europe Antihistamine Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Europe Antihistamine Drugs Sales Volume Market Share Forecast by Application in 2022
Table Europe Antihistamine Drugs Sales (K Units) Forecast by Antihistanmines (2017-2022)
Figure Europe Antihistamine Drugs Sales (K Units) Forecast by Antihistanmines (2017-2022)
Figure Europe Antihistamine Drugs Sales Volume Market Share Forecast by Antihistanmines in 2022
Table Europe Antihistamine Drugs Sales (K Units) Forecast by Access (2017-2022)
Figure Europe Antihistamine Drugs Sales (K Units) Forecast by Access (2017-2022)
Figure Europe Antihistamine Drugs Sales Volume Market Share Forecast by Access in 2022


More Publications